BioSpace News Archive

BioCina Expands Partnership with GPN Vaccines

BioCina Pty Ltd. announced the expansion of their partnership with GPN Vaccines Ltd. GPN Vaccines is a biotechnology company developing a proprietary engineered whole-cell vaccine called Gamma-PN™ against Streptococcus pneumoniae.

November 6, 2023
·
3 min read
TILT Biotherapeutics Announces Positive Clinical Data on Lead Asset TILT-123 at Society for Immunotherapy of Cancer 2023

TILT Biotherapeutics presented Phase I data on its TILT-123 monotherapy, a T-cell activating oncolytic virus for advanced solid tumor patients, in a late-breaking poster at the Society for Immunotherapy of Cancer 2023 conference.

November 6, 2023
·
4 min read
XNK Therapeutics announces poster presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

XNK Therapeutics AB participates in the SITC meeting, which takes place in San Diego, USA, and will present the latest research relating to the company’s leading natural killer cell therapies.

November 6, 2023
·
3 min read
Yemaachi Presents Findings on Mutation Profiles of Ghanaian Women with Breast Cancer at AORTIC 2023; Announces Formation of African Clinical Cancer Research Network

Yemaachi, the company dedicated to advancing precision oncology research and care in Africa for the benefit of patients everywhere, recently shared findings from a sequencing study in an abstract and poster presentation at the 14th AORTIC International Conference on Cancer in Africa.

November 6, 2023
·
2 min read
BioNxt Solutions Reports on Barcelona CPHI Conference

BioNxt Solutions Inc. is pleased to report on a successful CPHI pharma conference in Barcelona, Spain, recently attended by BioNxt’s European team.

November 6, 2023
·
3 min read
Business

Enhanc3D Genomics Expands Leadership Team With the Appointment of Hazel Jones as Chief Operating Officer

Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, announced the appointment of Hazel Jones as Chief Operating Officer.

November 6, 2023
·
3 min read
Drug Development

CRISPR Therapeutics Announces Preclinical Data at the American Heart Association (AHA) Scientific Sessions 2023

CRISPR Therapeutics announced preclinical data from the Company’s investigational programs for the treatment of cardiovascular disease, at the American Heart Association Scientific Sessions 2023.

November 6, 2023
·
6 min read
AliveDx receives IVDR Certification of its Manufacturing Sites in Switzerland and United Kingdom

AliveDx announced it has now received IVDR Certification for both its state-of-the-art manufacturing facilities located in Eysins, Switzerland and Edinburgh, United Kingdom.

November 6, 2023
·
2 min read
Drug Development

Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission

Kodiak Sciences Inc. announced that its Phase 3 GLOW superiority study evaluating tarcocimab tedromer 5 mg in moderately severe to severe NPDR met its one-year primary endpoint.

November 6, 2023
·
12 min read
Drug Development

Phase I Study Results for Qilu Pharmaceutical’s Iparomlimab (QL1604) Now Published

Recently, the results of the Phase I study for iparomlimab, developed by Qilu Pharmaceutical Co., Ltd. were published online in the academic journal Frontiers in Immunology.

November 6, 2023
·
4 min read